The Phenotypic variation of Candida albicans and susceptibility to fluconazole and voriconazole
author
Abstract:
Candida albicans is the most frequent opportunistic fungal agent in human being. One of its virulence factors is phenotypic switching. In this study, we investigated the susceptibility of different phenotypes of C. albicans, obtained from clinical specimens, to fluconazole (FLZ) and voriconazole (VRZ) with microdilution reference method. In this study, 281 C. albicans of six different phenotypes including 66.19% smooth, 11.38% stipple, 8.89% fuzzy, 6.40% star, 4.27% irregular and 2.84% ring form were collected. Among these specimens, 75.80% and 88.61% of the phenotypes were susceptible (s), 13.52% and 5.96% were susceptible, but dose dependent and finally 10.67% and 1.77% were resistant (r) to FLZ and VRZ, respectively. Most of (s) samples were smooth form and most (r) forms were stipple. The mean minimum inhibitory concentration of FLZ was higher than VRZ. In general, two antifungal medicines were effective on different phenotypes of C. albicans. Samples of (s) group had a significant difference with (r) group (p
similar resources
Profile susceptibility to fluconazole and voriconazole antifungals by species of Candida albicans isolated from urine culture
Background The term candiduria can be defined as the observation of yeasts on direct examination of urine through the presence of pseudo-hyphae and fungal growth in urine culture [1]. The yeast Candiduria can be detected in the urine in patients who have bladder colonization and in patients who have urinary tract infection [2]. Currently, there are few options in the medicine antifungal market ...
full textIn vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.
The aim of this study was to investigate the susceptibility of the different phenotypes of Candida albicans strains isolated from clinical specimens to three antifungal agents, fluconazole, itraconazole and voriconazole. Totally 215 specimens were collected from oropharyngeal, gastrointestinal and urogenital tracts of non-neutropenic patients who had received no previous prophylactic treatment....
full textA Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
We showed that a Candida albicans petite mutant in which oxidative phosphorylation is uncoupled was eightfold more resistant to fluconazole and voriconazole than SC5314 but equally susceptible to ketoconazole, itraconazole, and amphotericin B. Strain P5 significantly overexpressed MDR1, which likely accounts for the decreased drug susceptibility.
full textUsing PCR to Compare the Expression of CDR1, CDR2, and MDR1 in Candida Albicans Isolates Resistant and Susceptible to Fluconazole
Abstract Background and objectives: More Candida albicans strains are reported resistant to fluconazole in patients with AIDS, cancer and organ recipients. Fluconazole resistance can be attributed to changes in pathways of sterol biosynthesis, mutation in or overexpression of ERG11 and the expression of CDR1, CDR2, and MDR1. This study aimed to compare the ex...
full textThe alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.
OBJECTIVES To evaluate the effect of Candida albicans mitochondrial respiratory status on antifungal azole susceptibility. METHODS The inhibitors cyanide and salicylhydroxamic acid (SHAM) were each combined with azoles to examine the effect of the combinations on C. albicans. C. albicans strains deleted for the alternative oxidase (Aox) were also examined for susceptibility to azoles and for ...
full textReliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
The Vitek 2 yeast susceptibility test was evaluated by testing 122 Candida isolates against fluconazole and voriconazole. Excellent categorical agreement with the CLSI broth microdilution method was observed (97.5% for both the azoles). Moreover, the Vitek 2 system was able to identify all but 2 of 59 investigated fluconazole-resistant organisms.
full textMy Resources
Journal title
volume 72 issue 2
pages 101- 105
publication date 2017-07-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023